Concomitant Septal Myectomy in Patients Undergoing Aortic Valve Replacement for Severe Aortic Stenosis
|
|
- Marilyn Anderson
- 6 years ago
- Views:
Transcription
1 Circulation Journal Official Journal of the Japanese Circulation Society ORIGINAL ARTICLE Cardiovascular Surgery Concomitant Septal Myectomy in Patients Undergoing Aortic Valve Replacement for Severe Aortic Stenosis Ju Yong Lim, MD; Jin Oh Choi, MD; Jae Kon Oh, MD; Zhou Li; Soon J. Park, MD Background: Patients with severe aortic stenosis (AS) are often found to have asymmetric septal hypertrophy (ASH). With low sensitivity of echocardiography for detecting dynamic left ventricular outflow tract (LVOT) obstruction in severe AS, we adopted a routine intraoperative inspection of LVOT strategy for aortic valve replacement (AVR), and performed concomitant septal myectomy (CSM) as necessary. We sought to (1) evaluate surgical outcomes of CSM, (2) suggest preoperative echocardiographic parameters that correlate with findings of ASH, and (3) determine the predictors of CSM. Methods and Results: A single surgeon performed AVR for moderate-to-severe AS in 301 patients from 2007 to CSM was performed in 35 (11.6%) patients, resulting in AVR vs. AVR+CSM groups. Echocardiographic parameters, including the ratio of LVOT to aortic annular diameter (LVOT/AA), were compared. Mortality rate was comparable between groups (P=0.37). There were no postoperative complications related to CSM. The AVR+CSM group had a smaller LVOT/AA ratio (P=0.0012). The predictor of CSM was implanted valve size 21 mm (odds ratio 3.2, confidence interval , P=0.002). Conclusions: CSM can be performed safely at the time of AVR. The preoperative echocardiographic LVOT/AA ratio may help in detecting ASH. As an implanted valve size 21 mm was the only risk factor for CSM, careful assessment of LVOT is important in patients with a small aortic annulus. (Circ J 2015; 79: ) Key Words: Aortic valve replacement; Hypertrophic cardiomyopathy; Septal myectomy Asymmetric septal hypertrophy (ASH) was previously reported to be present in approximately 10% of cases of hemodynamically significant valvular aortic stenosis (AS). 1 This type of hypertrophy combined with severe AS can be easily overlooked at the time of aortic valve replacement (AVR), which can lead to residual left ventricular outflow track (LVOT) obstruction following AVR and a deteriorating postoperative course. 2,3 Although the indication for concomitant septal myectomy (CSM) at the time of AVR remains controversial, there have been suggestions supporting the necessity of direct inspection of LVOT at the time of AVR to assess the severity of ASH, 4 6 because of the low sensitivity of echocardiography for detecting dynamic LVOT obstruction in the setting of severe AS. We adopted the strategy of performing a direct visual and manual inspection of the LVOT in the operation room in all patients at the time of AVR and performed CSM in patients who were found to have ASH at the time of AVR, irrespective of their echocardiographic findings. Thus the aims of the current study were to: (1) evaluate the surgical outcomes of CSM, (2) suggest preoperative echocardiographic parameters that could predict the intraoperative finding of ASH requiring CSM, and (3) determine the other predictors of CSM at the time of AVR. Methods Study Population We adopted our intraoperative inspection strategy to detect ASH at the time of AVR in 2007 and until June 2012, inspection was performed in 301 patients by a cardiac surgeon (S.J.P.). We excluded patients who were diagnosed with hypertrophic obstructive cardiomyopathy or had known septal hypertrophy. CSM was performed in 35 patients on the basis of the intraoperative inspection (AVR+CSM group) and the other patients were grouped as AVR alone (n=266). The Institutional Review Board of the Mayo clinic approved this study (IRB no ). Received June 22, 2014; revised manuscript received November 3, 2014; accepted November 19, 2014; released online December 15, 2014 Time for primary review: 15 days Division of Cardiovascular Surgery (J.Y.L., S.J.P.), Division of Cardiology (J.O.C.), Division of Biostatistics (Z.L.), Mayo Clinic, Rochester, MN; Division of Cardiovascular Surgery, Case Western Reserve University, Cleveland, OH (S.J.P.), USA; Division of Cardiovascular Surgery, Asan Medical Center, Seoul (J.Y.L.); and Division of Cardiology, Samsung Medical Center, Seoul (J.O.C., J.K.O.), Korea Mailing address: Soon J. Park, MD, Chief, Division of Cardiovascular Surgery, Co-director, Harrington Heart and Vascular Institute, Case Western Reserve University, Euclid Ave, Cleveland, OH 44106, USA. soon.park@uhhospitals.org ISSN doi: /circj.CJ All rights are reserved to the Japanese Circulation Society. For permissions, please cj@j-circ.or.jp
2 376 LIM JY et al. 2.3±1.6 years. Statistical Analysis Statistical analyses were performed using SAS 9.13 (SAS Institute, Cary, NC, USA). Data are expressed as mean ± standard deviation for continuous variables and as numbers and percentages for categorical variables. Preoperative and postoperative measurements were compared using Student s pairedt test. Chi-square test or Fisher s exact test was used to compare the categorical variables and to assess statistical significance between the 2 groups. P<0.05 was considered statistically significant for all comparisons. Multivariate analysis was performed for the overall patient group using a Cox proportional hazards model. Variables were included in multivariate analysis if univariate significance was <0.05. The survival rate was calculated using Kaplan-Meier analysis. The follow-up period for each patient was calculated from the date of operation to the date of death or last contact. Figure 1. Echocardiographic measurement of left ventricular outflow tract/aortic annulus (LVOT/AA). A, LVOT; B, AA; LVOT/ AA=A/B. Operative Technique Median sternotomy was performed in all patients. After establishing standard extracorporeal circulation, cardiac arrest was induced with cold blood cardioplegia. Calcified native aortic valve (AV) was excised through oblique aortotomy and the aortic annulus (AA) was debrided carefully. Next, the LVOT was inspected visually and manually. If prominent septal bulging was detected, we performed standard septal myectomy avoiding conduction tissue injury. Prosthetic AV was placed in the annulus using standard technique. Echocardiographic Evaluation The pathology of the AV was preoperatively confirmed by transthoracic echocardiography (TTE). Severe AS was diagnosed with TTE by measuring the AV peak transvalvular pressure gradient, mean transvalvular pressure gradient and the AV orifice area in the systolic phase. Combined aortic regurgitation was graded from trivial (+1) to severe (+4) based on the regurgitant flow acceleration. Ventricular septal diameter and posterior free wall diameter were also measured preoperatively in the parasternal long-axis view. If the septal-free wall ratio was greater than 1.3, ASH was considered to be present. LVOT diameter at the level of 1 2 cm below the AA at end-diastole in the parasternal long-axis view (Figure 1) were measured retrospectively by an echocardiographer who was unaware of the surgical procedures and the LVOT diameter to AA ratio (LVOT/AA ratio) was calculated. As the LVOT was inspected only through the AA in the operating room, we hypothesized that the LVOT/AA ratio on preoperative echocardiography would correlate with the finding on intraoperative inspection of ASH requiring CSM. Patient Follow-up Last follow-up was obtained by social security death index, postal questionnaire and review of medical records. Follow-up was completed in 100%. Mean follow-up duration was Results The preoperative baseline characteristics of the patients are summarized in Table 1. There were more female patients in the AVR+CSM group (P=0.0026) and body surface area (BSA) was significantly smaller in the AVR+CSM group (P=0.0049). Except for these characteristics, there were no significant differences in the baseline characteristics of the 2 groups. Etiology of AS was mostly degenerative valve disease in both groups. Moderate-to-severe aortic regurgitation was concomitant in 74 patients in the AVR group and in 10 in AVR+CSM group. As shown in Table 2, aortic cross-clamp and total bypass times were not different between groups. The mean mass of the resected septal muscle for the patients in the AVR+CSM group was 1.03±0.6 g. Patients in the AVR+CSM group tended to have a smaller prosthetic valve compared with the AVR group (P=0.002). Concomitant procedures were performed in 65% of the patients in both groups. The most common concomitant procedure was coronary artery bypass grafting. There were 6 in hospital deaths, only in the AVR group, and the overall survival rate was comparable between groups (P=0.68) (Figure 2). The postoperative complication rate was comparable between groups in terms of re-exploration for bleeding, stroke, atrial fibrillation and renal failure. Complete atrioventricular block requiring permanent pacemaker occurred in only 3 patients in the AVR group, which did not show any statistical significance (P=0.83). Postoperative data from the last echocardiographic followup are shown in Table 3. Different from the preoperative echocardiographic findings in which LV end-systolic and enddiastolic dimensions (LVESD, LVEDD) were significantly smaller in AVR+CSM group, these dimensions became comparable postoperatively. Preoperative TTE Parameter (LVOT/AA) and Intraoperative Findings The LVOT/AA ratio in the diastolic phase in the AVR+CSM group was 0.81±0.11, which was significantly smaller than in the AVR group (0.89±0.09, P<0.001). This corroborated the high correlation between intraoperative inspection of the LVOT and the LVOT/AA value on preoperative TTE. Univariate and Multivariate Analysis for Risk Factor of CSM at the Time of AVR To determine the risk factors contributing to ASH requiring CSM at the time of AVR, univariate and multivariate analyses
3 Septal Myectomy With AVR 377 Table 1. Preoperative Characteristics of Patients With Severe AS Variable AVR group AVR+CSM group (n=266) (n=35) P value Age (years) 71.4± ± Female, n (%) 90 (33.8) 21 (60) * Body surface area, m ± ± * Hypertension 205 (77.0) 27 (77.1) 0.99 Diabetes mellitus 67 (25.2) 11 (31.4) 0.43 Hypercholesterolemia 40 (15.1) 1 (2.8) 0.57 Chronic lung disease 53 (19.7) 8 (22.8) 0.24 Chronic renal insufficiency 6 (2.3) 1 (2.8) 0.82 Peripheral vascular disease 31 (11.6) 7 (20) 0.16 Cerebrovascular accident 18 (19.1) 3 (8.6) 0.84 NYHA class III, IV 172 (64.7) 23 (65.7) 0.90 Etiology, n (%) 0.42 Degenerative 180 (67.7) 28 (80) Rheumatic 10 (3.76) 1 (2.8) Bicuspid 55 (20.7) 4 (11.4) LVEF (%) 55.4± ±13.3 <0.001 Aortic regurgitation 0.97 Trivial to mild 150 (56.4) 20 (57.1) Moderate to severe 74 (27.8) 10 (28.6) AV mean PG (mmhg) 47.1± ± LV mass 263.3± ± LV mass index 132.8± ± LVESD 36.1± ± * LVEDD 52.1± ± * *P<0.05. AS, aortic stenosis; AV, aortic valve; LV, left ventricle; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; NYHA, New York Heart Association; PG, pressure gradient. Table 2. Operative and Postoperative Data of Patients Undergoing Surgical Treatment of AS Variable AVR group (n=266) AVR+CSM group (n=35) P value Cardiopulmonary bypass time (min) 111.2± ± Aortic cross-clamp time (min) 81.7± ± Implant valve size 21 mm 92 (34.5) 22 (62.8) 0.002* Concomitant procedures, n (%) 175 (65.8) 23 (65.7) 1.0 CABG Ascending aorta replacement 18 1 Mitral repair or replacement 17 5 Tricuspid repair or replacement 6 1 Early death, n (%) 6 (2.26) Late death, n (%) 52 (19.5) 6 (17.1) 0.73 Cardiac death 11(4.1) 3 (8.6) 0.42 Postoperative complications, n (%) Re-exploration for bleeding 20 (7.5) 1 (2.8) 0.31 AVB requiring PPM 3 (1.1) Stroke 8 (3.0) 2 (5.7) 0.34 Atrial fibrillation 72 (27.1) 10 (28.6) 0.85 Renal failure 18 (6.8) 2 (5.7) 0.81 *P<0.05. AVB, atrioventricular block; CABG, coronary artery bypass grafting; PPM, permanent pacemaker. Other abbreviation as in Table 1. for CSM. For the multivariate analysis, we excluded the LVOT/AA ratio, which was the strongest risk factor from the univariate analysis, because this variable was obtained retrowere performed. In the univariate analysis, sex, BSA, implant valve size 21 mm, preoperative LVESD and LVEDD, and the LVOT/AA ratio were found to be significant risk factors
4 378 LIM JY et al. Figure 2. Overall survival curve. AVR, aortic valve replacement; CSM, concomitant septal myectomy. Table 3. Postoperative Echocardiographic Data of Patients Undergoing Surgical Treatment of AS Variable AVR group AVR+CSM group P value LVEF 55.3± ± LV mass 231.1± ± LV mass index 115.3± ± LVESD 35.0± ± LVEDD 50.7± ± AV mean PG 16.7± ± TTE follow-up duration 24± ± TTE, transthoracic echocardiography. Other abbreviations as in Table 1. spectively to determine the preoperative echocardiographic parameter that correlates with the intraoperative inspection findings and may represent the presence of ASH. Multivariate analysis demonstrated that small implant valve size ( 21 mm) was the only risk factor for CSM (odds ratio 3.2, confidence interval , P=0.002). These findings are summarized in Table 4. The best cutoff point for predicting CSM at the time of AVR was LVOT/AA <0.7. Discussion Significant ASH in patients with severe AS occurs in approximately 10% of cases. 4,7 In our study, it was 11.6% (35 of 301 patients), which is comparable. Considering that the incidence of valvular AS is increasing and most common among valvular heart disease, 8 ASH combined with severe AS is not a rare condition. The strategy for managing ASH at the time of AV surgery remains controversial because there has not been an evaluation in a large cohort or in a randomized controlled trial. Some studies recommend no routine resection of ASH at the time of AV surgery because of possible CSM-related complications such as the need for permanent pacemaker or septal perforation. 9 or suggest CSM only in the limited cases of dynamic LVOT obstruction with septal anterior motion. 4 However, there are several reasons to advocate CSM with AVR. First of all, CSM could eliminate any potential subaortic gradient unmasked after AVR. In the setting of combined ASH with severe AS, operative relief of AS only will unmask residual subaortic stenosis by ASH and this can lead to deleterious clinical outcomes in the early and late postoperative period Also, septal hypertrophy and small LV cavity diameter, as shown in the present AVR+CSM group, may be related to poor outcome in the long term if it remains. 13 CSM also could promote significant LV regression after surgery and it is a relatively safe procedure with an acceptable, low risk. 6,14,15 As shown in our study results, CSM did not add any postoperative complications or contribute to prolonged operation time. However, we failed to demonstrate differences between groups in the current study regarding the echocardiographic variables estimating regression of LV hypertrophy
5 Septal Myectomy With AVR 379 Table 4. Univariate and Multivariate Analyses for Risk Factors of ASH Requiring CSM in Patients Undergoing Surgical Treatment of AS Variable Odds ratio 95% CI P value Univariate analysis Age Sex * BSA * Diabetes Hypertension Renal failure NYHA III, IV Trans AV PG Implanted valve size 21 mm LVEF * LV mass index LVESD * LVEDD IVS LVOT/AA <0.001* Multivariate analysis Implanted valve size 21 mm * *P<0.05. ASH, asymmetric septal hypertrophy; BSA, body surface area; CI, confidence interval; CSM, concomitant septal myectomy; IVS, interventricular septum; LVOT/AA, left ventricular outflow tract/aortic annulus. Other abbreviations as in Table 1. after surgery. Regarding regression of LV hypertrophy, Seo et al insist that LV diastolic dysfunction persists for up to 5 years after uneventful AVR because of inadequate or incomplete regression of LV hypertrophy, 16 and Di Tommaso et al reported the benefit of CSM on LV regression. 4 The mean follow-up duration in the present study was 2.3±1.6 years, so longer follow-up might be necessary to clarify this issue. The remaining issue associated with this surgical approach is how the coexistence of ASH with severe AS can be diagnosed precisely before AV surgery. Pressure gradient itself is not reliable for detecting coexisting subaortic obstruction in the setting of severe AS. 17 Despite recent technical advances with 3D echocardiography, 18 transesophageal echocardiography as well as TTE may fail to detect ASH preoperatively. Therefore, some authors suggest that both visual and manual inspection of LVOT intraoperatively are important and the decision on whether to perform CSM at the time of AVR should be made by the operator based on the inspection after excision of the native AV. 4,6,14 We began a strategy of inspecting the LVOT to detect ASH at the time of AV surgery in all patients regardless of their preoperative echocardiographic findings from 2007 onward. Based on the intraoperative findings, we performed CSM. The inspection could be subjective, so we aimed to find some echocardiographic parameters that correlated and corroborated the surgeon s inspection findings. As shown in our study results, the preoperative LVOT/AA ratio strongly correlated with the intraoperative finding of a requirement for CSM. This suggests that the diagnostic acuity of TTE regarding ASH combined with severe AS may improve by using this parameter. Study Limitations First, this study was a retrospective observational study, not a randomized controlled study. So the comparison between groups could be biased with potential compounding factors. Second, the study population was relatively small, partly be- cause of strict inclusion criteria, which were adopted to improve the homogeneity of the study population and to verify the strategy of our surgical approach to ASH with severe AS. Also, the follow-up duration was relatively short because the intraoperative inspection strategy was introduced only 5 years prior. Longer follow-up with a larger population may provide enough statistical power to demonstrate differences in LV regression between CSM+AVR and AVR alone as previously reported. Conclusions Intraoperative findings of ASH in patients undergoing AVR for moderate-to-severe AS do not seem to be uncommon, and CSM for ASH can be performed without additional risks. Preoperative echocardiographic measurement of the LVOT/ AA ratio may be helpful in corroborating the intraoperative finding of ASH. As the implanted valve size 21 mm was the only risk factor for CSM, a careful assessment of the LVOT is important in patients with a small AA and small LVOT/AA ratio (LVOT/AA <0.7) at the time of AVR. None related to this study. Disclosures References 1. Maron BJ, Clark CE, Henry WL, Fukuda T, Edwards JE, Mathews EC, et al. Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart diseases: Echocardiographic and morphologic findings. Circulation 1977; 55: Parker DP, Kaplan MA, Connolly JE. Coexistent aortic valvular and functional hypertrophic subaortic stenosis: Clinical, physiologic and angiographic aspects. Am J Cardiol 1969; 24: Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, et al. Hypertrophic cardiomyopathy: The importance of the site and the extent of hypertrophy (Review). Prog Cardiovasc Dis 1985;
6 380 LIM JY et al. 28: Panza JA, Maron BJ. Valvular aortic stenosis and asymmetric septal hypertrophy: Diagnostic considerations and clinical and therapeutic implications. Eur Heart J 1988; 9(Suppl E): Turina M. Asymmetric septal hypertrophy should be resected during aortic valve replacement. Z Kardiol 1986; 75(Suppl 2): Di Tommaso L, Stassano P, Mannacio V, Russolillo V, Monaco M, Pinna G, et al. Asymmetric septal hypertrophy in patients with severe aortic stenosis: The usefulness of associated septal myectomy. J Thorac Cardiovasc Surg 2013; 145: Hess OM, Schneider J, Turina M, Carroll JD, Rothlin M, Krayenbuehl HP. Asymmetric septal hypertrophy in patients with aortic stenosis: An adaptive mechanism or a coexistence of hypertrophic cardiomyopathy? J Am Coll Cardiol 1983; 1: Wilton E, Jahangiri M. Post-stenotic aortic dilatation. J Thorac Cardiovasc Surg 2006; 1: Schulte HD, Bircks W, Horstkotte D, Kerstholt J, Preusse CJ, Winter J. Asymmetric septal hypertrophy (ASH) in valvular aortic stenosis should not be resected at the time of surgery. Z Kardiol 1986; 75(Suppl 2): Bird JJ, Murgo JP, Pasipoularides A. Fluid dynamics of aortic stenosis: Subvalvular gradients without subvalvular obstruction. Circulation 1982; 66: Aurigemma G, Battista S, Orsinelli D, Sweeney A, Pape L, Cuenoud H. Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis: A marker for high postoperative morbidity and mortality. Circulation 1992; 86: López Ayerbe J, Evangelista Masip A, Armada Romero E, Mateos González M, González Alujas MT, García Del Castillo H, et al. Predictive factors of abnormal dynamic intraventricular gradient after valve replacement in severe aortic stenosis. Rev Esp Cardiol 2002; 55: (in Spanish). 13. Goto D, Kinugawa S, Hamaguchi S, Sakakibara M, Tsuchihashi- Makaya M, Yokota T, et al. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: Report from the registry data in Japan. J Cardiol 2013; 61: Kayalar N, Schaff HV, Daly RC, Dearani JA, Park SJ. Concomitant septal myectomy at the time of aortic valve replacement for severe aortic stenosis. Ann Thorac Surg 2010; 89: Tasca G, Amaducci A, Parrella PV, Troise G, Dalla Tomba M, Magna Z, et al. Myectomy-myotomy associated with aortic valve replacement for aortic stenosis: Effects on left ventricular mass regression. Ital Heart J 2003; 4: Seo JS, Jang MK, Lee EY, Yun SC, Kim DH, Song JM, et al. Evaluation of left ventricular diastolic function after valve replacement in aortic stenosis using exercise doppler echocardiography. Circ J 2012; 76: Efthimiadis GK, Paqourelias ED, Parcharidou D, Gossios T, Kamperidis V, Theofiloqiannakos EK, et al. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction. Circ J 2013; 77: Song JK. Role of noninvasive imaging modalities to better understanding the mechanism of left ventricular outflow tract obstruction and tailored lesion-specific treatment options. Circ J 2014; 78:
Asymmetric septal hypertrophy in patients with severe aortic stenosis: The usefulness of associated septal myectomy
Asymmetric septal hypertrophy in patients with severe aortic stenosis: The usefulness of associated septal myectomy Luigi Di Tommaso, MD, Paolo Stassano, MD, Vito Mannacio, MD, Veronica Russolillo, MD,
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationIncidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Ömer Aktug 1, MD; Guido Dohmen 2, MD; Kathrin Brehmer 1, MD; Verena Deserno 1 ; Ralf Herpertz 1 ; Rüdiger
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationClinical material and methods. Fukui Cardiovascular Center, Fukui, Japan
Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationSeptal Myectomy, Papillary Muscle Resection, and Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy: A Case Report
Case Report Septal Myectomy, Papillary Muscle Resection, and Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy: A Case Report Junichiro Takahashi, MD, 1 Yutaka Wakamatsu, MD, 1 Jun Okude,
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationThe Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationRisk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects
Korean J Thorac Cardiovasc Surg 2017;50:78-85 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) CLINICAL RESEARCH https://doi.org/10.5090/kjtcs.2017.50.2.78 Risk Analysis of the Long-Term Outcomes of the
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationECHOCARDIOGRAPHY DATA REPORT FORM
Patient ID Patient Study ID AVM - - Date of form completion / / 20 Initials of person completing the form mm dd yyyy Study period Preoperative Postoperative Operative 6-month f/u 1-year f/u 2-year f/u
More informationLate secondary TR after left sided heart disease correction: is it predictibale and preventable
Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary
More informationIndicator Mild Moderate Severe
Indicator Mild Moderate Severe Jet velocity (m/s) 2.0-2.9 3.0-3.9 4.0 Mean gradient (mmhg) < 20 20-39 40 Valve area (cm 2 ) 1.0 Valve area index (cm 2 /m 2 ) 0.6 1 Abnormal AV with Reduced Systolic Opening
More informationWhich Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?
Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationEchocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis
The Egyptian Heart Journal (2013) 65, 135 139 Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Echocardiographic variables associated
More informationEffect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival
Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran,
More informationEarly Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons
Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons Duk-Hyun Kang, M.D. Division of Cardiology Asan Medical Center Seoul, Korea Background Dilemma of balancing the risks versus benefits
More informationDevelopment of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations
Imaging and Diagnostic Testing Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Jae-Jin Kwak, MD, a Yong-Jin
More informationJournal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 44, 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.062 Relation
More informationORIGINAL PAPER. R. C. Steggerda & J. C. Balt & K. Damman & M. P. van den Berg & J. M. ten Berg
Neth Heart J (2013) 21:504 509 DOI 10.1007/s12471-013-0453-4 ORIGINAL PAPER Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest
More informationExperience with 500 Stentless Aortic Valve Replacements
Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest
More informationBulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair
Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair Sameh M. Said, MD, Hartzell V. Schaff, MD, Rakesh M. Suri, MD, DPhil, Kevin L. Greason, MD, Joseph
More informationAortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -
Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo
More informationComprehensive Echo Assessment of Aortic Stenosis
Comprehensive Echo Assessment of Aortic Stenosis Smonporn Boonyaratavej, MD, MSc King Chulalongkorn Memorial Hospital Bangkok, Thailand Management of Valvular AS Medical and interventional approaches to
More informationPROSTHETIC VALVE BOARD REVIEW
PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationQuality Outcomes Mitral Valve Repair
Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding
More informationGender Differences in Valvular Heart Disease. Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences
Gender Differences in Valvular Heart Disease Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences Obstacles Interest in gender differences is a relatively new phenomenon Registries/RCT
More informationAnn Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article
Ann Thorac Cardiovasc Surg 2015; 21: 53 58 Online April 18, 2014 doi: 10.5761/atcs.oa.13-00364 Original Article The Impact of Preoperative and Postoperative Pulmonary Hypertension on Long-Term Surgical
More informationmarked increase in thickness of walls of heart in patient with HCM.
Surgical Management of Hypertrophic Obstructive Cardiomyopathy Hani K. Najm MD, Msc, FRCSC, FRCS (Glasg Glasg), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationMid-term results in patients having tricuspidization of the quadricuspid aortic valve
Song et al. Journal of Cardiothoracic Surgery 2014, 9:29 RESEARCH ARTICLE Open Access Mid-term results in patients having tricuspidization of the quadricuspid aortic valve Meong Gun Song 1, Hyun Suk Yang
More informationKinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands
Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart
More informationSince first successfully performed by Jatene et al, the
Long-Term Predictors of Aortic Root Dilation and Aortic Regurgitation After Arterial Switch Operation Marcy L. Schwartz, MD; Kimberlee Gauvreau, ScD; Pedro del Nido, MD; John E. Mayer, MD; Steven D. Colan,
More informationAortic stenosis (AS) is common with the aging population.
New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting
More informationThe Management of HOCM: What are the Surgical Options
The Management of HOCM: What are the Surgical Options Konstadinos A Plestis, MD System Chief of Cardiac Thoracic and Vascular Surgery Main Line Health Care System Professor Sidney Kimmel Medical College
More informationEchocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Original Article
Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Abstract Arezoo Khosravi (1), Hadi Sheykhloo (2), Reza Karbasi-Afshar (1), Amin Saburi (3) Original
More information(Ann Thorac Surg 2008;85:845 53)
I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable
More informationMedical Policy and and and and
ARBenefits Approval: 10/12/2011 Effective Date: 01/01/2012 Revision Date: Code(s): 93799, Unlisted cardiovascular service or procedure Medical Policy Title: Percutaneous Transluminal Septal Myocardial
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationIndication, Timing, Assessment and Update on TAVI
Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationAortic Valve Practice Guidelines: What Has Changed and What You Need to Know
Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts
More informationCase. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)
Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography
More informationAortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology
Aortic Stenosis: UPDATE 2010 Anjan Sinha, MD Krannert Institute of Cardiology None Disclosures 67-Year-Old Male Dyspnea and angina Class III heart failure No PND or orthopnea 3/6 late peak SEM Diminished
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationThe modified Konno procedure, or subaortic ventriculoplasty,
Modified Konno Procedure for Left Ventricular Outflow Tract Obstruction David P. Bichell, MD The modified Konno procedure, or subaortic ventriculoplasty, first described by Cooley and Garrett in1986, 1
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationTransthoracic Echocardiographic
Transthoracic Echocardiographic Findings of Mitral Regurgitation Caused by Commissural Prolapse 1 Hyue Mee Kim, 1 Kyung-Jin Kim, 1 Hyung-Kwan Kim*, 1 Jun-Bean Park, 2 Ho-Young Hwang, 3 Yeonyee E. Yoon,
More informationRestrictive Cardiomyopathy
ESC Congress 2011, Paris Imaging Unusual Causes of Cardiomyopathy Restrictive Cardiomyopathy Kazuaki Tanabe, MD, PhD Professor of Medicine Chair, Division of Cardiology Izumo, Japan I Have No Disclosures
More informationTricuspid and Pulmonic Valve Disease
Chapter 31 Tricuspid and Pulmonic Valve Disease David A. Tate Acquired disease of the right-sided cardiac valves is much less common than disease of the leftsided counterparts, possibly because of the
More informationProsthesis-Patient Mismatch or Prosthetic Valve Stenosis?
EuroValves 2015, Nice Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis? Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE FESC Canada Research Chair in Valvular Heart Diseases Université LAVAL Disclosure
More informationAortic valve replacement for severe aortic regurgitation in asymptomatic patients with normal ejection fraction and severe left ventricular dilatation
Interactive CardioVascular and Thoracic Surgery 22 (2016) 425 430 doi:10.1093/icvts/ivv365 Advance Access publication 30 December 2015 ORIGINAL ARTICLE ADULTCARDIAC Cite this article as: Wang Y, Shi J,
More informationPersistent Tricuspid Regurgitation After Tricuspid Annuloplasty During Redo Valve Surgery Affects Late Survival and Valve-Related Events
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Advance Publication by-j-stage Persistent Tricuspid Regurgitation After Tricuspid Annuloplasty During Redo
More informationSurgical Myectomy for HOCM
Surgical Myectomy for HOCM Volkmar Falk Deutsches Herzzentrum Berlin Different Pathology of HOCM Impact on surgical strategy Said SM Expert Rev Cardiovasc Ther 2013 Different Pathology of HOCM Impact on
More informationThe operative mortality rate after redo valvular operations
Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationMass Reduction and Functional Improvement of the Left Ventricle after Aortic Valve Replacement for Degenerative Aortic Stenosis
Korean J Thorac Cardiovasc Surg 2011;44:399-405 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) Clinical Research http://dx.doi.org/10.5090/kjtcs.2011.44.6.399 Mass Reduction and Functional Improvement
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationAlcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. CardioVascular Research Foundation
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Alcohol Septal Ablation (ASA) Nonsurgical technique for septal myocardial reduction Dramatic hemodynamic improvement Technically easy
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationHafþór Ingi Ragnarsson. Thesis for the Degree of Bachelor of Science University of Iceland Faculty of Medicine School of Health Sciences
Rates of and predictors for the need of permanent pacemaker and its long-term utilization in patients undergoing surgical or transcatheter aortic valve replacement Hafþór Ingi Ragnarsson Thesis for the
More informationAortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC
Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC No Financial Disclosures Aortic Stenosis AS is an insidious disease with a long latency period followed by
More informationClinical predictors of prosthesis-patient mismatch after aortic valve replacement for aortic stenosis
CLINICS 2012;67(1):55-60 DOI:10.6061/clinics/2012(01)09 CLINICAL SCIENCE Clinical predictors of prosthesis-patient mismatch after aortic valve replacement for aortic stenosis Luis M. Astudillo, I Orlando
More informationSurvival Benefit of Aortic Valve Replacement in Older Patients With Asymptomatic Chronic Severe Aortic Regurgitation
Survival Benefit of Aortic Valve Replacement in Older Patients With Asymptomatic Chronic Severe Aortic Regurgitation Rami Turk, MD, Padmini Varadarajan, MD, Ashvin Kamath, BA, Unnati Sampat, MD, Sumit
More information*The first two authors contributed equally to this work
Original Research Hellenic J Cardiol 2014; 55: 132-138 Surgical Septal Myectomy for Hypertrophic Cardiomyopathy in Greece: A Single-Center Initial Experience Georgios K. Efthimiadis 1*, Antonis Pitsis
More informationOptimal Imaging Technique Prior to TAVI -Echocardiography-
2014 KSC meeting Optimal Imaging Technique Prior to TAVI -Echocardiography- Geu-Ru Hong, M.D. Ph D Associate Professor of Medicine Division of Cardiology, Severance Cardiovascular Hospital Yonsei University
More informationIdiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis
CASE REPORTS Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis Martin J. Nathan, M.D., Roman W. DeSanctis, M.D., Mortimer J. Buckley, M.D., Charles A. Sanders, M.D., and W. Gerald Austen,
More informationSotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.
CORONARY ARTERY REVASCULARIZATION WITH MILD AORTIC STENOSIS: STRATEGIES OF TREATMENT 9 th ANNUAL MEETING OF THE EAB SOCIETY, Pravets, Bulgaria, 2012 Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. Director
More informationOutcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era
Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era Sebastian A. Iturra, Rakesh M. Suri, Kevin L. Greason, John
More informationOptions for my no option Patients Treating Heart Conditions Via a Tiny Catheter
Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Nirat Beohar, MD Associate Professor of Medicine Director Cardiac Catheterization Laboratory, Medical Director Structural
More informationReverse left atrium and left ventricle remodeling after aortic valve interventions
Reverse left atrium and left ventricle remodeling after aortic valve interventions Alexandra Gonçalves, Cristina Gavina, Carlos Almeria, Pedro Marcos-Alberca, Gisela Feltes, Rosanna Hernández-Antolín,
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More informationRest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome
Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome G. Deswarte, AS. Polge, N. Lamblin, A. Millaire, M. Richardson, C. Bauters,
More informationCardiac ultrasound protocols
Cardiac ultrasound protocols IDEXX Telemedicine Consultants Two-dimensional and M-mode imaging planes Right parasternal long axis four chamber Obtained from the right side Displays the relative proportions
More informationSeverity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root
The role of Cardiac Imaging modalities in evaluation & selection of patients for Trans-catheter Aortic Valve Implantation Dr.Saeed AL Ahmari Consultant Cardiologist Prince Sultan Cardaic Center, Riyadh
More informationSevere left ventricular dysfunction and valvular heart disease: should we operate?
Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict
More informationPPM: How to fit a big valve in a small heart
PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat
More informationICE: Echo Core Lab-CRF
APPENDIX 1 ICE: Echo Core Lab-CRF Study #: - Pt Initials: 1. Date of study: / / D D M M M Y Y Y Y 2. Type of Study: TTE TEE 3. Quality of Study: Poor Moderate Excellent Ejection Fraction 4. Ejection Fraction
More informationThe Edge-to-Edge Technique f For Barlow's Disease
The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele
More informationEmergency Intraoperative Echocardiography
Emergency Intraoperative Echocardiography Justiaan Swanevelder Department of Anaesthesia, Glenfield Hospital University Hospitals of Leicester NHS Trust, UK Carl Gustav Jung (1875-1961) Your vision will
More informationInfluence of Atrial Fibrillation on Outcome Following Mitral Valve Repair
Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Eric Lim, MBChB, MRCS; Clifford W. Barlow, DPhil, FRCS; A. Reza Hosseinpour, FRCS; Christopher Wisbey, BA; Kate Wilson, RN, BSc;
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationIntra-operative Echocardiography: When to Go Back on Pump
Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria
More informationManagement of Incomplete Initial Repair in the Treatment of Degenerative Mitral Insufficiency An Institutional Protocol and Mid-Term Outcomes
CLINICAL STUDY Management of Incomplete Initial Repair in the Treatment of Degenerative Mitral Insufficiency An Institutional Protocol and Mid-Term Outcomes Wenrui Ma, 1 MD, Wei Shi, 1 MD, Wei Zhang, 1
More informationOutline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines
Advances in Percutaneous Mitral Valve Repair and Replacement Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando,
More informationCoexistence of asymmetric septal hypertrophy and aortic valve disease in adults
Thorax, 1979, 34, 91-95 Coexistence of asymmetric septal hypertrophy and aortic valve disease in adults M V J RAJ, V SRINIVAS, I M GRAHAM, AND D W EVANS From the Regional Cardiac Unit, Papworth Hospital,
More informationThe surgical management of hypertrophic obstructive cardiomyopathy with the concomitant mitral valve abnormalities
Interactive CardioVascular and Thoracic Surgery 21 (2015) 722 726 doi:10.1093/icvts/ivv257 Advance Access publication 15 September 2015 ORIGINAL ARTICLE ADULTCARDIAC Cite this article as: Cui B, Wang S,
More informationMuscular (hypertrophic) subaortic stenosis (hypertrophic obstructive cardiomyopathy): the evidence for true obstruction
Postgraduate Medical Journal (1986) 62, 531-536 Muscular (hypertrophic) subaortic stenosis (hypertrophic obstructive cardiomyopathy): the evidence for true obstruction to left ventricular outflow E. Douglas
More informationHOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?
HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? John D. Carroll, MD Professor, Director of Interventional Cardiology and Co-Medical Director of the Cardiac and Vascular Center, University of Colorado
More information좌심실수축기능평가 Cardiac Function
Basic Echo Review Course 좌심실수축기능평가 Cardiac Function Seonghoon Choi Cardiology Hallym university LV systolic function Systolic function 좌심실수축기능 - 심근의수축으로심실에서혈액을대동맥으로박출하는기능 실제임상에서 LV function 의의미 1Diagnosis
More informationResults of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency
Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Ken-ichi ASANO, M.D., Masahiko WASHIO, M.D., and Shoji EGUCHI, M.D. SUMMARY (1) Surgical results of
More informationWhen Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea
When Should We Consider TAVI Procedure in Korea (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea Aortic Stenosis in Korea Rapidly increasing valve disease in Korea Still low incidence
More informationRestoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery
Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery John M. Stulak, MD,* Hartzell V. Schaff, MD, Joseph A. Dearani, MD, Thomas A. Orszulak,
More information